Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions

Genes Chromosomes and Cancer

Volumn 50, Issue 1, 2011, Pages 25-33

  Guo, Tianhua ^a   Zhang, Lei ^a   Chang, Ning En ^a   Singer, Samuel ^a   Maki, Robert G ^a   Antonescu, Cristina R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; VASCULOTROPIN RECEPTOR 3;

ANGIOSARCOMA; ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; ONCOGENE MYC; PATHOGENESIS; PRIORITY JOURNAL; RADIATION INDUCED ANGIOSARCOMA; RADIATION INDUCED ATYPICAL VASCULAR LESION; RADIATION INDUCED NEOPLASM; TUMOR GROWTH; VASCULAR LESION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENES, MYC; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM PROTEINS; NEOPLASMS, RADIATION-INDUCED; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MYC; RADIOTHERAPY; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 78249289103     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20827     Document Type: Article

References (21)

1. Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, DeMatteo RP. 2005. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 11: 4182-4190.
2. Antonescu CR, Yoshida A, Guo T, Chang NE, Zhang L, Agaram NP, Qin LX, Brennan MF, Singer S, Maki RG. 2009. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer Res 69: 7175-7179.
3. Blackwood MJ. 1994. Utilization management and data acquisition: A case study. Benefits Q 10: 38-42.
4. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO. 2003. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 100: 10623-10628.
5. Choschzick M, Lassen P, Lebeau A, Marx AH, Terracciano L, Heilenkotter U, Jaenicke F, Bokemeyer C, Izbicki J, Sauter G, Simon R. 2010. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome. Mod Pathol 23: 603-610.
6. Gengler C, Coindre JM, Leroux A, Trassard M, Ranchere-Vince D, Valo I, Michels JJ, Guillou L. 2007. Vascular proliferations of the skin after radiation therapy for breast cancer: Clinicopathologic analysis of a series in favor of a benign process: A study from the French Sarcoma Group. Cancer 109: 1584-1598.
7. Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR. 2007. Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor. Clin Cancer Res 13: 4874-4881.
8. Hamlyn PH, Rabbitts TH. 1983. Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene. Nature 304: 135-139.
9. Hann SR, Dixit M, Sears RC, Sealy L. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev 8: 2441-2452.
10. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25: 153-159.
11. Kozbor D, Croce CM. 1984. Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. Cancer Res 44: 438-441.
12. Kretzner L, Blackwood EM, Eisenman RN. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359: 426-429.
13. Lagrange JL, Ramaioli A, Chateau MC, Marchal C, Resbeut M, Richaud P, Lagarde P, Rambert P, Tortechaux J, Seng SH, de la Fontan B, Reme-Saumon M, Bof J, Ghnassia JP, Coindre JM. 2000. Sarcoma after radiation therapy: Retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Federation Nationale des Centres de Lutte Contre le Cancer. Radiology 216: 197-205.
14. Mankey CC, McHugh JB, Thomas DG, Lucas DR. 2010. Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas. Histopathology 56: 364-371.
15. Manner J, Radlwimmer B, Hohenberger P, Mossinger K, Kuffer S, Sauer C, Belharazem D, Zettl A, Coindre JM, Hallermann C, Hartmann JT, Katenkamp D, Katenkamp K, Schoffski P, Sciot R, Wozniak A, Lichter P, Marx A, Strobel P. 2010. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 176: 34-39.
16. Ramsay G, Evan GI, Bishop JM. 1984. The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci USA 81: 7742-7746.
17. 1/S arrest following ionizing radiation. Mol Cell Biol 22: 1819-1833.
18. Sheppard DG, Libshitz HI. 2001. Post-radiation sarcomas: A review of the clinical and imaging features in 63 cases. Clin Radiol 56: 22-29.
19. Spotts GD, Patel SV, Xiao Q, Hann SR. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol 17: 1459-1468.
20. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P. 1982. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79: 7837-7841.
21. Watson PH, Safneck JR, Le K, Dubik D, Shiu RP. 1993. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902-907.